{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T14:58:12Z","timestamp":1648565892429},"reference-count":37,"publisher":"Cambridge University Press (CUP)","issue":"4","license":[{"start":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T00:00:00Z","timestamp":1402617600000},"content-version":"unspecified","delay-in-days":1655,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ir. j. psychol. Med."],"published-print":{"date-parts":[[2009,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Objectives:<\/jats:bold>The objectives of the study were to identify the characteristics of the patients who were commenced in a newly developed opiate substitute prescribing (OSP) programme, to determine their rate of retention and to ascertain the patients' opinions of the service. We also wished to determine rates of blood borne viruses in this population.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold>Data were collected from three sources: the Shaftesbury Square Hospital Substitute Prescribing Database, patient charts and an anonymous user views questionnaire. We also conducted viral screening. Inclusion criteria were opiate dependence according to ICD-10<jats:sup>1<\/jats:sup>for at least one year, in individuals who were 18 years of age or older. The sample comprised the first 80 patients who attended the service, who were followed up over two years.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold>A total of 44% of our original cohort remained engaged with the service two years after commencement. Of the remainder, 18% engaged with OSP elsewhere and 13% completed a successful detoxification from all opiate drug use. Factors which were associated with continuation in the programme were prescription of methadone (as compared with buprenorphine), female sex and higher doses of OSP. Patients reported high levels of satisfaction with the service. Of those who were tested for blood borne viruses, more than half were positive for hepatitis C infection.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold>The response to the development of the opiate substitution programme demonstrated that there was a need in the community which had not been met in the past. Service users who attended the programme reported high levels of satisfaction.<\/jats:p>","DOI":"10.1017\/s0790966700000665","type":"journal-article","created":{"date-parts":[[2016,3,15]],"date-time":"2016-03-15T13:06:11Z","timestamp":1458047171000},"page":"183-186","source":"Crossref","is-referenced-by-count":1,"title":["Opiate substitution prescribing in Belfast \u2013 two year follow up study"],"prefix":"10.1017","volume":"26","author":[{"given":"Ruth","family":"Collins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Ewing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bob","family":"Boggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel","family":"Taggart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aileen","family":"Drillingcourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2014,6,13]]},"reference":[{"key":"S0790966700000665_ref036","volume-title":"Good practice in harm reduction","year":"2008"},{"key":"S0790966700000665_ref030","volume-title":"Infections among injecting drug users in the United Kingdom 2006","year":"2007"},{"key":"S0790966700000665_ref009","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(99)00077-0"},{"key":"S0790966700000665_ref022","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-9089-3"},{"key":"S0790966700000665_ref002","volume-title":"Northern Ireland Guidelines on Substitution Treatment for Opiate Dependence","year":"2004"},{"key":"S0790966700000665_ref035","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2002.00079.x"},{"key":"S0790966700000665_ref016","doi-asserted-by":"publisher","DOI":"10.1016\/0899-3289(95)90309-7"},{"key":"S0790966700000665_ref017","doi-asserted-by":"publisher","DOI":"10.1016\/S0899-3289(05)80007-0"},{"key":"S0790966700000665_ref005","doi-asserted-by":"publisher","DOI":"10.3109\/00952999309002666"},{"key":"S0790966700000665_ref018","first-page":"239","article-title":"Treatment retention and follow up outcomes in the Drug Abuse Treatment Outcome Study","volume":"11","author":"Simpson","year":"1997","journal-title":"Psychol Addictive Behav"},{"key":"S0790966700000665_ref033","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1037\/0893-164X.11.4.279","article-title":"Overview of one-year outcomes in the Drug Abuse Treatment Outcome Study (DATOS)","volume":"11","author":"Hubbard","year":"1997","journal-title":"Psychol Addictive Behav"},{"key":"S0790966700000665_ref014","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5694\/j.1326-5377.1991.tb121030.x","article-title":"Methadone dosage and retention of patients in maintenance treatment","volume":"154","author":"Capelhorn","year":"1991","journal-title":"Med J Aust"},{"key":"S0790966700000665_ref011","doi-asserted-by":"publisher","DOI":"10.1037\/0893-164X.11.4.261"},{"key":"S0790966700000665_ref001","volume-title":"Symptom Checklist for Mental Disorders, Versions 1.1","author":"Janca","year":"1994"},{"key":"S0790966700000665_ref024","volume-title":"The Cochrane Database of Systematic Reviews","author":"Faggiano","year":"2003"},{"key":"S0790966700000665_ref027","first-page":"139","article-title":"The Effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence","volume":"55","author":"Simeons","year":"2005","journal-title":"Br J Gen Practice"},{"key":"S0790966700000665_ref003","first-page":"1259","volume":"97","author":"Gossop","year":"2002","journal-title":"Factors associated with abstinence, lapse or relapse to heroin use after residential treatment Addiction"},{"key":"S0790966700000665_ref004","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.187.4.360"},{"key":"S0790966700000665_ref006","volume-title":"Drug Misuse 2004: Reducing the Local Impact","year":"2004"},{"key":"S0790966700000665_ref007","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1989.tb00786.x"},{"key":"S0790966700000665_ref008","doi-asserted-by":"publisher","DOI":"10.1002\/cbm.339"},{"key":"S0790966700000665_ref010","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2005.02.008"},{"key":"S0790966700000665_ref029","unstructured":"Northern Ireland Statistics and Research Agency. Dept of Health Social Services and Public Safety Statistical Bulletin 2007. www.dhsspsni.gov.uk"},{"key":"S0790966700000665_ref013","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4603(94)00052-Z"},{"key":"S0790966700000665_ref015","doi-asserted-by":"publisher","DOI":"10.1037\/0893-164X.11.4.216"},{"key":"S0790966700000665_ref020","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(00)00211-8"},{"key":"S0790966700000665_ref021","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00963.x"},{"key":"S0790966700000665_ref023","first-page":"65","article-title":"Methadone dose and heroin use during maintenance treatment","volume":"88","author":"Capelhorn","year":"1993","journal-title":"Addiction"},{"key":"S0790966700000665_ref025","volume-title":"Methadone dose and methadone maintenance treatment","year":"2004"},{"key":"S0790966700000665_ref031","volume-title":"Outcome of waiting lists study Waiting times for drug treatment: effects on uptake and immediate outcomes","author":"Donmall","year":"2005"},{"key":"S0790966700000665_ref032","first-page":"4","article-title":"The Grand Design Lessons from DATOS","volume":"7","author":"Franey","year":"2002","journal-title":"Drug and Alcohol Findings"},{"key":"S0790966700000665_ref034","doi-asserted-by":"publisher","DOI":"10.1081\/ADA-100101854"},{"key":"S0790966700000665_ref037","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(98)00037-3"},{"key":"S0790966700000665_ref026","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(03)00146-9"},{"key":"S0790966700000665_ref019","volume-title":"Models of care for the treatment of adult drug misusers","year":"2005"},{"key":"S0790966700000665_ref028","unstructured":"Statistics from the Northern Ireland Drug Misuse Database: 1 April 2006-31 March 2007. Northern Ireland Statistics and Research Agency. Dept of Health, Social Services and Public Safety Stastical Bulletin October 2007."},{"key":"S0790966700000665_ref012","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00296.x"}],"container-title":["Irish Journal of Psychological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0790966700000665","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T05:13:12Z","timestamp":1600319592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0790966700000665\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0790966700000665"],"URL":"https:\/\/doi.org\/10.1017\/s0790966700000665","relation":{},"ISSN":["0790-9667","2051-6967"],"issn-type":[{"value":"0790-9667","type":"print"},{"value":"2051-6967","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}